BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 5577153)

  • 1. Proteolytic enzymes. VI. Aromatic amidines as competitive inhibitors of trypsin.
    Tanizawa K; Ishii S; Hamaguchi K; Kanaoka Y
    J Biochem; 1971 May; 69(5):893-9. PubMed ID: 5577153
    [No Abstract]   [Full Text] [Related]  

  • 2. Irreversible enzyme inhibitors. CLII. Proteolytic enzymes. X. Inhibition of guinea pig complement by substituted benzamidines.
    Baker BR; Erickson EH
    J Med Chem; 1969 May; 12(3):408-14. PubMed ID: 5788155
    [No Abstract]   [Full Text] [Related]  

  • 3. Changes in the exposure of the tyrosyl and tryptophyl residues in trypsin due to diisopropylphosphoryl and benzamidine inhibition.
    Villanueva GB; Herskovits TT
    Biochemistry; 1971 Nov; 10(24):4589-94. PubMed ID: 5142621
    [No Abstract]   [Full Text] [Related]  

  • 4. Irreversible enzyme inhibitors. CVI. Proteolytic enzymes. I. Bulk tolerances in trypsin-inhibitor complexes.
    Baker BR; Erickson EH
    J Med Chem; 1967 Nov; 10(6):1123-8. PubMed ID: 6056041
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative studies on the inhibition of trypsin, plasmin, and thrombin by derivatives of benzylamine and benzamidine.
    Markwardt F; Landmann H; Walsmann P
    Eur J Biochem; 1968 Dec; 6(4):502-6. PubMed ID: 5701967
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition studies of soybean trypsin-like enzyme.
    Nishikata M
    J Biochem; 1985 Jun; 97(6):1541-9. PubMed ID: 4040908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrophobic interactions in the trypsin active center. The sensitivity of the hydrophobic binding site to side chain modifications in competitive inhibitors of the amidinium type.
    Mares-Guia M
    Arch Biochem Biophys; 1968 Sep; 127(1):317-22. PubMed ID: 5697989
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on the effect of ring substitution on the thrombin inhibition effect of benzylamine- and benzamidine derivatives].
    Markwardt F; Walsmann P; Kazmirowski HG
    Pharmazie; 1969 Jul; 24(7):400-2. PubMed ID: 5810249
    [No Abstract]   [Full Text] [Related]  

  • 9. The modification of essential carboxylic acid side chains of trypsin.
    Feinstein G; Bodlaender P; Shaw E
    Biochemistry; 1969 Dec; 8(12):4949-55. PubMed ID: 5365788
    [No Abstract]   [Full Text] [Related]  

  • 10. Modification of carboxyl groups in the binding sites of trypsin with the Meerwein reagent.
    Nakayama H; Tanizawa K; Kanaoka Y
    Biochem Biophys Res Commun; 1970 Aug; 40(3):537-41. PubMed ID: 5492151
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemical modifications of amino groups of trypsin.
    Nureddin A; Inagami T
    Biochem Biophys Res Commun; 1969 Sep; 36(6):999-1005. PubMed ID: 5344729
    [No Abstract]   [Full Text] [Related]  

  • 12. [Synthetic inhibitors of serine proteinases. 8. Inhibition of trypsin, plasmin and thrombin by means of amidinophenyl-derivatives with ketonic-structure].
    Stürzebecher J; Markwardt F; Richter P; Voigt B; Wagner G; Walsmann P
    Pharmazie; 1976 Jul; 31(7):458-61. PubMed ID: 135982
    [No Abstract]   [Full Text] [Related]  

  • 13. Trypsinogen, trypsin, trypsin-substrate and trypsin-inhibitor complexes in urea solutions.
    Delaage M; Lazdunski M
    Eur J Biochem; 1968 Apr; 4(3):378-84. PubMed ID: 5690131
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of acrosin by benzamidines.
    Stürzebecher J
    Acta Biol Med Ger; 1981; 40(10-11):1519-22. PubMed ID: 7044006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study on the interaction of soybean trypsin inhibitor with trypsin by circular dichroism.
    Ishida M; Hamaguchi K; Ikenaka T
    J Biochem; 1970 Mar; 67(3):363-71. PubMed ID: 5463779
    [No Abstract]   [Full Text] [Related]  

  • 16. Spin-labeled sulfonyl fluorides as active site probes of protease structure. I. Comparison of the active site environments in alpha-chymotrypsin and trypsin.
    Berliner LJ; Wong SS
    J Biol Chem; 1974 Mar; 249(6):1668-77. PubMed ID: 4361818
    [No Abstract]   [Full Text] [Related]  

  • 17. [Modification of thrombin activity by synthetic serine proteinase inhibitors].
    Walsmann P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 98(4):471-82. PubMed ID: 4121340
    [No Abstract]   [Full Text] [Related]  

  • 18. Thermodynamics of the hydrophobic interaction in the active center of trypsin. Investigation with amidines and guanidines.
    Mares-Guia M; Figueiredo AF
    Biochemistry; 1970 Aug; 9(16):3223-7. PubMed ID: 5489774
    [No Abstract]   [Full Text] [Related]  

  • 19. Irreversible enzyme inhibitors. CXV. Proteolytic enzymes. V. Active-site-directed irreversible inhibitors of trypsin derived from p-(phenoxyalkoxy) benzamidines with a terminal sulfonyl fluoride.
    Baker BR; Erickson EH
    J Med Chem; 1968 Mar; 11(2):245-9. PubMed ID: 5654210
    [No Abstract]   [Full Text] [Related]  

  • 20. STUDIES ON THE ACTIVE CENTER OF TRYPSIN. THE BINDING OF AMIDINES AND GUANIDINES AS MODELS OF THE SUBSTRATE SIDE CHAIN.
    MARES-GUIA M; SHAW E
    J Biol Chem; 1965 Apr; 240():1579-85. PubMed ID: 14285494
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.